Fig. 1From: Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathwayExperimental protocol. At the age of 25–26 week-old, ZL or ZDF rats were treated with Zn(ASA)2 or a polyethylene glycol vehicle (15 mg/kg) orally for 24 consecutive days. Zn(ASA) 2 indicates a zinc complex of acetylsalicylic acid, ZDF Zucker diabetic fatty rats, ZL Zucker leanBack to article page